Citations 0
January 1, 2005

Suture Tarsorrhaphy—Reply

Author Affiliations

Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005

Arch Ophthalmol. 2005;123(1):126. doi:10.1001/archopht.123.1.126-a

In reply

We appreciate the authors’ opinion and interest regarding our technique. Cyanoacrylate has been used for many years in ophthalmology and has been used by many experts in the field as an off-label use to create a temporary tarsorrhaphy. It is a well-known fact that cyanoacrylate has a limited duration of action when used in medical applications. However, for the patients who need decreased corneal exposure but who cannot tolerate an invasive tarsorrhaphy, such as those receiving anticoagulant therapy or those who won’t tolerate even a small needle to inject local anesthetic, as noted by the authors of the letter, this technique has its obvious advantages. The increased ease of application of the newer gel form of cyanoacrylate, for a patient bed-bound and in-house, makes this simple and noninvasive bedside procedure a very valuable one to have in our growing armamentarium of therapeutic interventions.

First Page Preview View Large
First page PDF preview
First page PDF preview